The identification of biomarkers for oncologic outcomes could guide risk-adapted treatment strategies. High neutrophil-tolymphocyte ratio (NLR) is a marker of systemic inflammation and together with the platelet-to-lymphocyte ratio (PLR) is associated with worse outcomes in several solid tumours. The aim of this study was to investigate the prognostic value of NLR and PLR in patients with head and neck squamous cell carcinoma (HNSCC) treated with primary or adjuvant (chemo)radiotherapy ((C)RT) and to correlate this parameters to acute toxicity.
PO-1073 NLR and PLR ratio as predictive markers of outcomes in head and neck squamous cell carcinoma
Porreca, A.;
2022-01-01
Abstract
The identification of biomarkers for oncologic outcomes could guide risk-adapted treatment strategies. High neutrophil-tolymphocyte ratio (NLR) is a marker of systemic inflammation and together with the platelet-to-lymphocyte ratio (PLR) is associated with worse outcomes in several solid tumours. The aim of this study was to investigate the prognostic value of NLR and PLR in patients with head and neck squamous cell carcinoma (HNSCC) treated with primary or adjuvant (chemo)radiotherapy ((C)RT) and to correlate this parameters to acute toxicity.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
